Echo Street Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,183
| Closed | -$368K | – | 573 |
|
|
2023
Q1 | $368K | Sell |
9,183
-2,154
| -19% | -$86.4K | ﹤0.01% | 336 |
|
|
2022
Q4 | $525K | Sell |
11,337
-4,371
| -28% | -$203K | 0.01% | 272 |
|
|
2022
Q3 | $650K | Buy |
+15,708
| New | +$650K | 0.01% | 224 |
|
|
2022
Q2 | – | Sell |
-3,219
| Closed | -$234K | – | 683 |
|
|
2022
Q1 | $234K | Buy |
+3,219
| New | +$234K | ﹤0.01% | 545 |
|
|
2021
Q4 | – | Sell |
-4,634
| Closed | -$418K | – | 732 |
|
|
2021
Q3 | $418K | Sell |
4,634
-6,773
| -59% | -$611K | ﹤0.01% | 462 |
|
|
2021
Q2 | $1.09M | Buy |
11,407
+5,170
| +83% | +$493K | 0.01% | 197 |
|
|
2021
Q1 | $710K | Buy |
+6,237
| New | +$710K | 0.01% | 228 |
|